Juan M. Rivero-Suarez
Sevilla, AN 41013, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Dexketoprofen enhances NLRP3 activation via ATPase activity after canonical stimuli.
Journal: Inflammopharmacology
Published: April 18, 2025
A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular Models.
Journal: Antioxidants (Basel, Switzerland)
Published: July 19, 2024
Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation.
Journal: Biomolecules
Published: April 15, 2024
The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice.
Journal: Aging cell
Published: April 10, 2024
Does NLRP1 Inflammasome Activation in Immune Cells in Kidney Transplantation Relate with Donor Organ Age?
Journal: Antioxidants & redox signaling
Published: March 18, 2024
Does Donor Age Have Effects on Senescence Biomarkers in Kidney-Transplanted Patients?
Journal: Antioxidants & redox signaling
Published: February 01, 2024
NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: January 03, 2024
NLRP1 inflammasome modulates senescence and senescence-associated secretory phenotype.
Journal: bioRxiv : the preprint server for biology
Published: February 17, 2023
Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration.
Journal: Neural regeneration research
Published: December 01, 2022
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases.
Journal: International journal of molecular sciences
Published: November 28, 2022
Last Updated: 09/26/2026